Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Christopher Longshaw"'
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 13, Iss 1, Pp 1-14 (2024)
Abstract Background Antibiotic resistance among Gram-negative bacteria in intensive care units (ICUs) is linked with high morbidity and mortality in patients. In this study, we estimated the therapeutic coverage of various antibiotics, focusing on ce
Externí odkaz:
https://doaj.org/article/6406336f213e42cf9de22a89d0a807ec
Autor:
Anne Santerre Henriksen, Fabio Arena, Marie Attwood, Rafael Canton, Sören Gatermann, Thierry Naas, Ian Morrissey, Christopher Longshaw
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 8 (2024)
ABSTRACT Carbapenem-resistant Enterobacterales represent a major health threat and have few approved therapeutic options. Enterobacterales isolates were collected from hospitalized inpatients from 49 sites in six European countries (1 January–31 De
Externí odkaz:
https://doaj.org/article/1f3d1d994d1a4cbbb99acb1bfe3c5808
Autor:
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D. Perry, Mathias W. Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 4 (2024)
ABSTRACTCarbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major threats and have few approved therapeutic options. Non-fermenting Gram-negative isolates were collected from hospitalized inpatients from 49 sites in 6 Euro
Externí odkaz:
https://doaj.org/article/31e59d823f274282a558d965c21030cc
Autor:
Christopher Longshaw, Anne Santerre Henriksen, Dana Dressel, Michelle Malysa, Christian Silvestri, Miki Takemura, Yoshinori Yamano, Takamichi Baba, Christine M. Slover
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT This study aimed to determine the proportion of heteroresistance in carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex (CRAB) isolates in the cefiderocol arm of the randomized, Phase 3 CREDIBLE-CR study by population analysis
Externí odkaz:
https://doaj.org/article/44c0581edd934caca23ab09f39213d90
Autor:
Philipp Thelen, Anne Santerre Henriksen, Christopher Longshaw, Yoshinori Yamano, Ben Caldwell, Axel Hamprecht
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 28, Iss , Pp 12-17 (2022)
ABSTRACT: Objectives: Widespread antimicrobial resistance in Gram-negative bacteria (GNB), particularly carbapenem resistance, represents a major clinical challenge. Cefiderocol is a novel siderophore cephalosporin active against all carbapenemase cl
Externí odkaz:
https://doaj.org/article/808fd1b51d7e4d768caeba4c990ba148
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 27, Iss , Pp 1-11 (2021)
ABSTRACT: Objectives: The prevalence of Gram-negative bacteria (GNB) demonstrating extensive, multiple antimicrobial resistance is increasing in England, leaving few treatment choices. Cefiderocol is a novel siderophore cephalosporin approved in Euro
Externí odkaz:
https://doaj.org/article/a73421aab0354d87bd825a8c87fef6f7
Autor:
Emilia Cercenado, Laura Cardenoso, Rocio Penin, Christopher Longshaw, Anne Santerre Henriksen, Alvaro Pascual
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 26, Iss , Pp 292-300 (2021)
ABSTRACT: Objectives: The incidence of antimicrobial resistance in Europe is rising. Cefiderocol is approved in Europe for treatment of aerobic Gram-negative bacterial (GNB) infections in adults with limited treatment options. We report the in vitro
Externí odkaz:
https://doaj.org/article/4354a84bcbc243e888634001375235c5
Autor:
Stefano Stracquadanio, Eleonora Torti, Christopher Longshaw, Anne Santerre Henriksen, Stefania Stefani
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss , Pp 390-398 (2021)
ABSTRACT: Objectives: : Antimicrobial resistance, particularly carbapenem resistance, in Gram-negative pathogens poses a significant healthcare threat. Carbapenem resistance rates in Italy are among the highest in Europe. We report the in vitro activ
Externí odkaz:
https://doaj.org/article/b2de32fe727547e9aebc4e4fa7a1c9cb
Autor:
Saoussen Oueslati, Pierre Bogaerts, Laurent Dortet, Sandrine Bernabeu, Hend Ben Lakhal, Christopher Longshaw, Youri Glupczynski, Thierry Naas
Publikováno v:
Antibiotics, Vol 11, Iss 10, p 1352 (2022)
Infections with carbapenem-resistant (CR) Gram-negative (GN) pathogens have increased in many countries worldwide, leaving only few therapeutic options. Cefiderocol (CFDC) is approved in Europe for the treatment of aerobic GN infections in adults wit
Externí odkaz:
https://doaj.org/article/ae55c1bd69414362946aef757a888286
Autor:
Guido Granata, Davide Manissero, Maria Vittoria Oppia, Keiko Tone, Bin Cai, Christopher Longshaw, Carolina Venditti, Nicola Petrosillo
Publikováno v:
Infectious Disease Reports, Vol 12, Iss 2 (2020)
There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated re
Externí odkaz:
https://doaj.org/article/de83b1f5fb7d4c7996e80c82d4973e2c